Find your next M&A target
Target Asia + Worldwide M&A projects with our guidance on matching, planning, due diligence & implementation.
Japanese lifestyle diseases drug developer seeks financing.
|Total value of the target||N/A|
|Expected target net rate of return after deducting all taxes and fees||N/A|
|Validity period of pending order||365|
Senior Associate, International Business Advisory
|Project highlights||diabetes - 7 product pipelines - jointly funded by three large companies|
The Japanese company mainly focuses on the development of new medicines for lifestyle diseases such as diabetes, hypertension, and hyperlipidemia. It currently has 7 product pipelines and three products of it have entered the Phase II clinical trial. The company is jointly funded by Innovation Network Corporation of Japan, Takeda and Medipal. Now it seeks financing.
Enquire for more information about our services, and how we can help solve challenges for your organizationContact Us